Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP-dependent RNA helicase DDX25 is a testis-specific enzyme in the DEAD-box protein family, characterized by the conserved Asp-Glu-Ala-Asp (DEAD) motif and is essential for mRNA export and translation regulation during spermatid development. DDX25 is regulated by gonadotropins in male gonadal cells, predominantly expressed in meiotic spermatocytes and round spermatids, where it is critical for the completion of spermatogenesis and normal sperm formation. Its functional activities include shuttling mRNAs from the nucleus to cytoplasmic sites, assisting in the formation and structural maintenance of chromatoid bodies, participating in miRNA biogenesis, and preventing apoptosis of germ cells. Functional ablation or mutations in DDX25 cause arrest in spermatid maturation and male infertility. While no direct drug interactions have been reported, other DEAD-box helicases are emerging therapeutic targets, especially in cancer, suggesting potential future interest in DDX25 as a target in reproductive medicine or oncology, although with concerns about fertility-related adverse effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-dependent RNA helicase DDX25 (DDX25).